Scarica l'app Stockscreener
0.5231
1.93%
-0.0111
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$0.5342
Aprire:
$0.5249
Volume 24 ore:
398.54K
Relative Volume:
0.12
Capitalizzazione di mercato:
$79.84M
Reddito:
$15.93M
Utile/perdita netta:
$-64.59M
Rapporto P/E:
-0.6975
EPS:
-0.75
Flusso di cassa netto:
$-59.50M
1 W Prestazione:
-3.94%
1M Prestazione:
+1.41%
6M Prestazione:
-39.89%
1 anno Prestazione:
-60.01%
Intervallo 1D:
$0.5121
$0.53
Intervallo di 1 settimana:
$0.51
$0.566
Portata 52W:
$0.45
$1.75
Veru Inc Stock (VERU) Company Profile
Nome
Veru Inc
Settore
Industria
Telefono
(312) 595-9123
Indirizzo
2916 N. MIAMI AVENUE, MIAMI, FL
Confronta VERU con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
VERU
Veru Inc
|
0.5235 | 79.84M | 15.93M | -64.59M | -59.50M | -0.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
473.93 | 127.47B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.78 | 62.43B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
594.51 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
229.93 | 31.06B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
228.81 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
Veru Inc Stock (VERU) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-05-14 | Iniziato | B. Riley Securities | Buy |
| 2024-03-28 | Iniziato | Raymond James | Outperform |
| 2023-06-07 | Aggiornamento | Jefferies | Underperform → Hold |
| 2021-04-13 | Iniziato | Jefferies | Buy |
| 2021-02-09 | Reiterato | H.C. Wainwright | Buy |
| 2020-01-21 | Reiterato | H.C. Wainwright | Buy |
| 2019-03-20 | Iniziato | Oppenheimer | Outperform |
| 2018-07-03 | Iniziato | Maxim Group | Buy |
Mostra tutto
Veru Inc Borsa (VERU) Ultime notizie
Veru to Present at the 2nd Annual GLP-1-Based Therapeutics Summi - GuruFocus
Veru to Present at the 2nd Annual GLP-1-Based Therapeutics Summit | VERU Stock News - GuruFocus
Veru to Present at the 2nd Annual GLP-1-Based Therapeutics Summit - GlobeNewswire
The Female Health Company Announces Board Changes - marketscreener.com
Veru Inc.'s (NASDAQ:VERU) 27% Price Boost Is Out Of Tune With Revenues - simplywall.st
DEADLINE ALERT for GPS, VERU, NEO, SI: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders - Louisiana First News
Veru Insiders Miss 24% Gain After Offloading Stock - simplywall.st
What Do Wall Street Analysts Think About Veru Inc (NASDAQ: VERU) Stock? - stocksregister.com
Veru to Participate in Fireside Chat at the Jones Healthcare and Technology Innovation Conference - GlobeNewswire
Veru Sees Unusually Large Options Volume (NASDAQ:VERU) - MarketBeat
Veru Inc. (NASDAQ:VERU) Stock Position Boosted by Atria Investments Inc - Defense World
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Veru, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action– VERU - Business Wire
Veru Inc. Shareholders Approve Equity Plan Amendment - TipRanks
VERU stock touches 52-week low at $0.47 amid market challenges - Investing.com Australia
VERU stock touches 52-week low at $0.47 amid market challenges By Investing.com - Investing.com South Africa
Here's Why Veru (VERU) Looks Ripe for Bottom Fishing - Yahoo Finance
Oppenheimer & Co. Inc. Boosts Stake in Veru Inc. (NASDAQ:VERU) - MarketBeat
B. Riley Cuts Price Target on Veru to $2 From $5, Keeps Buy Rating -March 07, 2025 at 07:49 am EST - Marketscreener.com
Veru Inc to Host Earnings Call - ACCESS Newswire
Down -9.23% in 4 Weeks, Here's Why Veru (VERU) Looks Ripe for a Turnaround - Yahoo Finance
VERU stock touches 52-week low at $0.49 amid market challenges - Investing.com Canada
Veru, Inc. to Host Earnings Call - ACCESS Newswire
Veru Inc. (NASDAQ:VERU) Director Acquires $52,403.45 in Stock - MarketBeat
Director Makes Bold Move with Major Veru Stock Purchase! - TipRanks
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Veru Inc. (VERU) Investors with Significant Losses to Contact Firm’s Attorneys, Deadline Approaching in Securities Class Action - ACCESS Newswire
3 US Penny Stocks With Market Caps Under $300M To Consider - Simply Wall St
Veru Inc. director Michael Rankowitz buys $84,350 in common stock - Investing.com
Veru Inc. director Michael Rankowitz buys $84,350 in common stock By Investing.com - Investing.com South Africa
Short Interest in Veru Inc. (NASDAQ:VERU) Rises By 14.3% - MarketBeat
Veru (NASDAQ:VERU) Releases Quarterly Earnings Results, Beats Expectations By $0.01 EPS - MarketBeat
Veru (NASDAQ:VERU) Issues Earnings Results - MarketBeat
Veru Inc. Reports Fiscal 2025 First Quarter Financial Results and Clinical Program ProgressVERU INC. (NASDAQ: VERU) recently released its financial results for the first quarter of fiscal 2025, along with key updates on its clinical development progr - Defense World
Earnings call transcript: Veru Inc Q1 2025 beats EPS forecast, stock dips - MSN
Veru Inc. (NASDAQ:VERU) Short Interest Up 14.3% in January - Defense World
Oppenheimer Adjusts Price Target on Veru to $4 From $5, Keeps Outperform Rating - Marketscreener.com
Veru Inc. (NASDAQ:VERU) Q1 2025 Earnings Call Transcript - Insider Monkey
Veru Inc Faces Uncertain Financial Future Amidst Lack of Revenue and Regulatory Hurdles - TipRanks
Veru Inc (VERU) Q1 2025 Earnings Call Highlights: Strategic Shif - GuruFocus
Veru Inc Azioni (VERU) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.77%
0.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):